Brad Stanfield: Weapon Against Alzheimer’s Just Got FDA-Approved
Peer-Reviewed Research
Key Takeaways
- Get tested early if you are aged 55+ and show early signs of cognitive decline using the new FDA-approved blood test for p-tau181 levels.
- Interpret test results cautiously: A negative result is 98% accurate in ruling out Alzheimer’s, but a positive result only has a 22% accuracy in confirming the disease and should be followed up with further scans.
- Avoid routine early testing without symptoms, as false positives can cause unnecessary stress and further testing.
- Be skeptical of online Alzheimer’s blood tests advertised as early detection tools before symptoms appear.
Bottom Line
Consider the new FDA-approved blood test for Alzheimer’s only if you are over 55 and show early signs of cognitive decline, and focus on prevention strategies to reduce risk factors.
Explore More
- Brad Stanfield’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network